All In Biotech

Free tool

FAERS Monitor: Viread

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022577 or its brand name (Viread, Tenofovir Disoproxil Fumarate). Reports on generic versions are filed under their own applications.

Reports

32,964

Serious

30,987

94% of reports

Hospitalization

6,403

Death reported

1,955

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • bone density decreased10,696
  • renal injury9,285
  • skeletal injury8,338
  • chronic kidney disease7,310
  • osteonecrosis7,271
  • bone loss7,084
  • multiple fractures6,842
  • renal failure6,700
  • osteoporosis5,420
  • tooth loss4,538
  • pain3,040
  • emotional distress2,861
  • anxiety2,677
  • anhedonia2,459
  • osteopenia2,270

Reports by year received

View as table
YearReports
2004578
2005639
2006526
2007566
2008530
2009573
2010473
2011556
2012495
2013530
2014932
20151,213
20161,209
20171,322
20181,506
20191,938
202012,186
20212,741
20221,734
20231,093
2024751
2025589
2026279

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,195 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
skeletal injurySignal8,3382640.12517.84,281,041
bone lossSignal7,084567.2550.42,120,373
multiple fracturesSignal6,842454.4441.41,808,582
bone density decreasedSignal10,696330.0323.22,315,185
renal injurySignal9,285289.4283.11,838,112
osteonecrosisSignal7,271181.1176.81,015,536
tooth lossSignal4,538178.4173.0626,144
osteopeniaSignal2,270112.0107.3212,542
osteoporosisSignal5,42096.794.2446,428
chronic kidney diseaseSignal7,31067.866.4436,429
anhedoniaSignal2,45965.863.2142,271
renal failureSignal6,70033.833.1204,070
emotional distressSignal2,86115.414.937,870
anxietySignal2,6776.05.811,325
painSignal3,0403.23.14,622

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.